PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $308,000 | -44.1% | 145,512 | -11.5% | 0.05% | -40.3% |
| Q3 2016 | $551,000 | +654.8% | 164,405 | +607.6% | 0.08% | +541.7% |
| Q2 2016 | $73,000 | +102.8% | 23,235 | +116.9% | 0.01% | +100.0% |
| Q1 2016 | $36,000 | -61.7% | 10,712 | -59.6% | 0.01% | -71.4% |
| Q4 2015 | $94,000 | -27.1% | 26,509 | +45.1% | 0.02% | -25.0% |
| Q1 2015 | $129,000 | +30.3% | 18,268 | +42.4% | 0.03% | +40.0% |
| Q4 2014 | $99,000 | – | 12,831 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |